Mounjaro vs. Wegovy: Does Wegovy Work as Well as Mounjaro for Weight Loss?

Introduction

Imagine navigating the vast landscape of weight loss solutions, constantly seeking a path that truly aligns with your body’s unique needs and your personal goals. For many, the journey to sustainable weight management can feel like a complex puzzle, often marked by frustration and cycles of limited success. In recent years, a new class of medications has emerged, offering promising breakthroughs, particularly in the realm of GLP-1 receptor agonists. Among these, Wegovy (semaglutide) and Mounjaro (tirzepatide) frequently stand out, sparking crucial conversations about their efficacy and distinct mechanisms. The question of whether does Wegovy work as well as Mounjaro is more than just a matter of comparing two medications; it delves into the intricate science of appetite regulation, metabolic health, and personalized care.

At TrimRx, our journey began with a shared vision to help individuals embrace healthier lifestyles by merging cutting-edge telehealth innovations with effective weight loss solutions. We understand that deciphering the differences between advanced treatments like Wegovy and Mounjaro is essential for making informed decisions on your health journey. This blog post is designed to be your comprehensive guide, exploring the science behind these powerful medications, comparing their effectiveness, and discussing how they fit into a holistic, personalized weight loss strategy. We will delve into how each medication interacts with your body, review the latest clinical findings, and highlight the importance of medical supervision and a supportive framework. By the end, you’ll have a clearer understanding of these options, empowering you to consider the best path forward for your unique needs. We believe that sustainable weight loss should be achieved through science, empathy, and a transparent approach, and we’re here to guide you every step of the way.

Understanding GLP-1 and Dual Agonists: The Science Behind Weight Loss Medications

To truly understand how medications like Wegovy and Mounjaro support weight loss, it’s essential to first grasp the fundamental science behind their action. Both belong to a class of drugs known as incretin mimetics, which are designed to mimic the natural hormones in your body that regulate appetite and blood sugar. Our understanding of these complex biological processes has advanced significantly, allowing for targeted and highly effective interventions.

The Role of GLP-1 in Appetite Regulation

Glucagon-like peptide-1 (GLP-1) is a natural hormone produced in the gut that plays a crucial role in metabolic regulation. When you eat, GLP-1 is released and acts on several fronts:

• Signals Satiety to the Brain: GLP-1 communicates with the brain, specifically the areas responsible for appetite control, helping you feel fuller and more satisfied after meals. This reduces cravings and overall food intake.
• Slows Gastric Emptying: It slows down the rate at which food leaves your stomach, contributing to prolonged feelings of fullness. This means you’re less likely to feel hungry again shortly after eating.
• Regulates Blood Sugar: GLP-1 stimulates the pancreas to release insulin when blood sugar levels are high, which helps transport glucose from the bloodstream into cells for energy, thereby lowering blood sugar. It also suppresses glucagon secretion, preventing the liver from releasing too much sugar.

Semaglutide, the active ingredient in Wegovy and Ozempic®, is a GLP-1 receptor agonist. It works by mimicking the effects of natural GLP-1, binding to the GLP-1 receptors in the body and amplifying these beneficial actions. This pharmacological enhancement helps individuals manage their appetite, reduce calorie intake, and achieve significant weight loss when combined with lifestyle interventions.

Introducing the Dual Action of GIP and GLP-1

While GLP-1 receptor agonists have proven highly effective, scientific advancements have led to the development of even more sophisticated mechanisms. Tirzepatide, the active ingredient in Mounjaro and Zepbound®, takes a unique dual-action approach. It mimics not only GLP-1 but also another incretin hormone called glucose-dependent insulinotropic polypeptide (GIP).

GIP, like GLP-1, is released after eating and plays a role in blood sugar regulation by stimulating insulin secretion. However, recent research has revealed that GIP also has independent effects on metabolism and fat storage. By activating both the GIP and GLP-1 receptors, tirzepatide offers a synergistic effect:

• Enhanced Satiety and Appetite Reduction: The combined action of GIP and GLP-1 can lead to even greater feelings of fullness and appetite suppression compared to GLP-1 alone.
• Improved Metabolic Efficiency: GIP is thought to influence fat metabolism directly, potentially encouraging fat reduction and preventing fat from accumulating. This dual targeting of both hunger signals and metabolic pathways is a key differentiator.

This dual-receptor agonism allows tirzepatide to potentially offer a more comprehensive approach to weight management and metabolic health. At TrimRx, we leverage the latest scientific understanding to provide you with treatment options that are at the forefront of weight loss innovation, ensuring you have access to solutions that align with the most current research. Our personalized programs, which include options like Ozempic®, Wegovy®, Mounjaro®, and Zepbound®, are designed to utilize these powerful mechanisms safely and effectively. To explore if these options are right for you, we encourage you to take our free assessment quiz.

Wegovy: The Semaglutide Journey for Weight Management

Wegovy, with its active ingredient semaglutide, represents a significant leap forward in medically supervised weight loss. Its development and subsequent FDA approval have provided a much-needed, effective tool for individuals struggling with obesity and weight-related health conditions.

FDA Approval and Efficacy of Wegovy

Wegovy was specifically approved by the U.S. Food and Drug Administration (FDA) in June 2021 for chronic weight management in adults with obesity (BMI of 30 or greater) or those who are overweight (BMI of 27 or greater) with at least one weight-related comorbidity, such as high blood pressure, type 2 diabetes, or high cholesterol. This approval marked a pivotal moment, affirming its role as a dedicated medication for weight loss.

Clinical trials have consistently demonstrated Wegovy’s effectiveness. The landmark STEP 1 clinical trial, which involved over 1,900 adults over 68 weeks, showed that participants taking semaglutide in conjunction with lifestyle interventions achieved an average weight loss of approximately 15-17% of their starting body weight. This level of weight loss is considered clinically meaningful and can significantly improve health outcomes associated with obesity. For example, a reduction of even 5-10% of body weight can lead to improvements in blood pressure, blood sugar control, and lipid profiles.

Dosing and Administration for Optimal Results

Wegovy is administered as a once-weekly subcutaneous injection using a pre-filled pen. The treatment begins with a low dose, typically 0.25 mg, and is gradually increased over several weeks to a maintenance dose, commonly 2.4 mg. This titration schedule is crucial, allowing your body to adjust to the medication and helping to minimize potential side effects. Our transparent service at TrimRx ensures that this approach remains consistent, providing you with a clear and guided path regardless of dosage changes. Each pen is designed to be user-friendly, containing four doses, making it convenient for at-home administration.

Adherence to the prescribed dosing schedule and injection technique is paramount for achieving the best results. Our comprehensive service includes initial doctor consultations to ensure proper guidance and understanding.

The Synergy of Medication and Lifestyle

It’s important to emphasize that Wegovy, like all effective weight management medications, is designed to be a powerful adjunct to a healthy lifestyle, not a replacement for it. For optimal and sustainable weight loss, it must be combined with a calorie-reduced diet and increased physical activity. The medication helps by curbing appetite and increasing feelings of fullness, making it easier to adhere to dietary changes.

At TrimRx, we champion a holistic approach to weight loss. While we partner with FDA-registered and inspected pharmacies for the shipping of prescription weight loss medications like Wegovy®, we also provide unlimited support to help you integrate sustainable healthy habits into your daily life. Our philosophy is that true transformation comes from a combination of advanced medical science and dedicated lifestyle adjustments.

For individuals seeking additional support in their wellness journey, our quick-access supplements are available without a quiz. Consider exploring our GLP-1 Daily Support or Weight Loss Boost to complement your regimen. If you’re ready to explore a personalized prescription treatment plan, we invite you to take our free assessment quiz to determine your eligibility.

Mounjaro and Zepbound: The Power of Tirzepatide

The introduction of tirzepatide, the active ingredient in Mounjaro and Zepbound, has further expanded the horizons of effective weight management. This innovative medication offers a distinct approach, leveraging a dual-action mechanism to deliver powerful results.

Mounjaro’s Foundation and Zepbound’s Dedicated Weight Loss Role

Initially, Mounjaro (tirzepatide) received FDA approval for the treatment of adults with type 2 diabetes. However, through rigorous clinical trials, it became evident that tirzepatide also led to significant weight loss in individuals with and without diabetes. This led to its widespread “off-label” use for weight management, a common practice in medicine when a drug approved for one condition shows benefit for another.

Recognizing the substantial weight loss benefits, Eli Lilly, the manufacturer, sought and received dedicated FDA approval for tirzepatide specifically for chronic weight management. This is where Zepbound comes in: it contains the exact same active ingredient, tirzepatide, as Mounjaro, but it is explicitly marketed and FDA-approved for weight loss. This distinction is crucial for understanding its intended use and for insurance coverage considerations. At TrimRx, we are proud to offer both Mounjaro® and Zepbound® as part of our personalized treatment options, ensuring you have access to FDA-approved solutions for your unique health profile.

The Dual-Action Advantage: GIP and GLP-1

As discussed earlier, tirzepatide’s unique strength lies in its dual agonism, mimicking both GLP-1 and GIP. This combined action targets two separate incretin pathways, leading to a potentially more robust impact on appetite suppression, satiety, and metabolic regulation.

Clinical trials have showcased impressive results with tirzepatide. The SURMOUNT-1 study, a 72-week trial examining tirzepatide in non-diabetic patients with obesity, reported that participants receiving the highest dose experienced an average weight loss of up to 22.5% of their starting body weight. Another study, SURMOUNT-5, confirmed this, finding that patients on tirzepatide experienced a 47% greater relative weight loss compared to semaglutide after 72 weeks, losing an average of 20.2% of body weight. These findings underscore the potential for tirzepatide to achieve even greater weight loss outcomes for many individuals.

Dosing and Administration of Tirzepatide

Similar to semaglutide, tirzepatide is administered as a once-weekly subcutaneous injection using a pre-filled pen. The dosing schedule for Mounjaro and Zepbound also involves a gradual escalation to allow the body to adapt. It typically starts at 2.5 mg and can be increased in increments, often every four weeks, up to a maximum dose of 15 mg. This careful titration process is vital for managing side effects and ensuring the body comfortably adjusts to the medication.

Our approach at TrimRx emphasizes compassionate care that respects every individual’s unique journey. When you embark on a personalized program with us, which could include Compounded Tirzepatide or Oral Tirzepatide, you receive comprehensive service that includes doctor consultations, any necessary lab work, unlimited support, and shipping directly from FDA-registered and inspected pharmacies, all with no hidden fees. We’re dedicated to making sustainable weight loss attainable and tailored to you.

Direct Comparison: Does Wegovy Work as Well as Mounjaro?

The central question for many individuals considering these advanced weight loss solutions is whether does Wegovy work as well as Mounjaro. While both medications are highly effective tools for weight management, recent head-to-head research suggests there are distinguishable differences in their average weight loss potential.

Insights from Head-to-Head Clinical Trials

The most compelling evidence regarding the comparative effectiveness of Wegovy and Mounjaro comes from direct head-to-head clinical trials. A significant study published in the New England Journal of Medicine in May 2025 (and reported in UK news outlets) directly compared tirzepatide (Mounjaro’s active ingredient) and semaglutide (Wegovy’s active ingredient) in individuals with obesity but without type 2 diabetes.

The findings were noteworthy:

• Participants treated with tirzepatide lost an average of 20.2% of their body weight.
• Participants treated with semaglutide lost an average of 13.7% of their body weight.

This data indicates a statistically significant difference, with tirzepatide demonstrating superior average weight loss. Furthermore, those on tirzepatide experienced greater reductions in waist circumference, with an average shrinkage of over 5cm more than those on semaglutide. This aligns with a larger study in JAMA Internal Medicine in 2024, which also found tirzepatide led to almost 7% more body weight being lost on average than semaglutide after one year among obese people with and without diabetes.

The “Why” Behind the Difference: Dual Agonism’s Impact

The prevailing scientific explanation for tirzepatide’s potentially greater efficacy lies in its dual-receptor agonism. By activating both GLP-1 and GIP receptors, tirzepatide engages a broader range of metabolic pathways involved in appetite regulation and energy expenditure. The GIP component is believed to offer additional benefits in fat metabolism and insulin sensitivity, which, when combined with the robust appetite suppression of GLP-1, can lead to a more pronounced and sustained reduction in body weight.

It’s an example of how combining advanced medical science with modern technology, like that found at TrimRx, can lead to even more effective solutions for our members. We are committed to empowering you with knowledge, ensuring you understand the mechanisms behind your treatment options.

Nuances in Effectiveness: Individual Variation and Personalized Care

While clinical trials provide valuable averages, it is crucial to remember that individual responses to medication can vary. Factors such as genetics, baseline weight, adherence to the treatment plan, and consistency with lifestyle changes all play a role in the actual outcomes. One medication might work better for one person, while another might find more success with a different option. This is why a personalized approach is not just a preference but a necessity in effective weight management.

At TrimRx, our brand is empathetic, innovative, trustworthy, supportive, results-oriented, and personalized. We understand that your weight loss journey is unique. That’s why we don’t offer a one-size-fits-all solution. Our platform is a user-friendly and supportive space where individuals receive personalized, medically supervised care, designed to make sustainable weight loss attainable and tailored to the individual. We offer a range of clinically proven options, including Compounded Semaglutide, Oral Semaglutide, Compounded Tirzepatide, and Oral Tirzepatide, alongside branded options like Ozempic®, Wegovy®, Mounjaro®, and Zepbound®.

To discover which of these powerful medications might be the best fit for your specific needs, we highly recommend that you take our free assessment quiz. This crucial first step helps us understand your health profile and recommend a tailored treatment plan.

Navigating Your Weight Loss Journey: Side Effects and Safety

When considering any prescription weight loss medication, understanding potential side effects and prioritizing safety are paramount. Both Wegovy and Mounjaro, while highly effective, come with their own profiles of adverse events, primarily due to their shared mechanisms of action. Our commitment at TrimRx is to ensure you have all the necessary information to make informed decisions and feel supported throughout your journey.

Common Side Effects

The most frequently reported side effects for both semaglutide (Wegovy) and tirzepatide (Mounjaro/Zepbound) are gastrointestinal in nature. These often include:

• Nausea: Feeling sick to your stomach.
• Diarrhea: Loose, watery stools.
• Constipation: Difficulty having bowel movements.
• Vomiting: Throwing up.
• Abdominal Pain: Discomfort in the stomach area.

These side effects are typically mild to moderate and tend to decrease over time as your body adjusts to the medication, especially during the gradual dose escalation (titration) period. The slow increase in dosage is a deliberate strategy to help manage and mitigate these initial discomforts. In clinical trials, a similar percentage of people experienced side effects on both weight-loss drugs, with around 77-79% reporting at least one side effect, most commonly digestive issues. However, some studies have indicated slight variations in the frequency of specific GI issues between the two medications.

Other less common but reported side effects include fatigue, dizziness, and headaches. It’s important to communicate any persistent or bothersome side effects with your healthcare provider.

Serious, Though Less Common, Risks

While rare, more serious adverse events can occur with both types of medications. These include:

• Pancreatitis: Inflammation of the pancreas.
• Gallbladder Problems: Including gallstones.
• Hypoglycemia (Low Blood Sugar): Especially in individuals also taking other diabetes medications.
• Kidney Problems: Worsening of kidney function, particularly in individuals with pre-existing kidney issues who experience severe dehydration from vomiting or diarrhea.
• Thyroid C-cell Tumors: In studies with rodents, these medications caused thyroid C-cell tumors. It is unknown if they cause these tumors in humans. Therefore, individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not use these medications.
• Allergic Reactions: Severe allergic reactions are possible, though uncommon.

Prioritizing Safety and Medical Supervision

Given the potential for side effects, both common and serious, these medications are prescription-only and require careful medical supervision. A thorough evaluation of your medical history, current health status, and other medications is essential to determine if Wegovy, Mounjaro, Zepbound, or any other prescription weight loss treatment is safe and appropriate for you.

At TrimRx, safety is a cornerstone of our values. We work exclusively with FDA-registered and inspected pharmacies for the shipping of all prescription weight loss medications, including Ozempic®, Wegovy®, Mounjaro®, and Zepbound®. Our comprehensive service includes vital doctor consultations and any necessary lab work to ensure your treatment plan is tailored to your health profile and continuously monitored for safety and effectiveness. We provide compassionate care and unwavering support, making sure you feel informed and secure at every stage of your weight loss journey. Remember, while we facilitate access to medication through our pharmacy partners, we emphasize that TrimRx itself does not provide actual medical supervision; instead, you receive care through our network of licensed medical providers.

It’s critical to avoid these medications if you are pregnant, planning to become pregnant, or breastfeeding. Similarly, individuals with type 1 diabetes or a history of diabetic retinopathy generally should not use them. Your health and safety are our top priorities.

Beyond Medication: The Holistic Approach to Sustainable Weight Loss

While medications like Wegovy and Mounjaro offer powerful support for weight loss, we at TrimRx firmly believe that true, sustainable transformation is achieved through a comprehensive and holistic approach. These medications are most effective when integrated into a broader strategy that encompasses healthy eating, regular physical activity, and ongoing support.

The Indispensable Role of Lifestyle Changes

Think of prescription weight loss medications as a vital tool in your toolkit, not the entire solution. They can significantly reduce appetite and enhance feelings of fullness, making it much easier to adhere to a calorie-reduced diet. They help silence the constant hunger cues that often derail weight loss efforts. However, the habits you build around your diet and exercise regimen are what will ultimately lead to long-term success and maintenance of your weight loss.

• Nutrient-Dense Diet: Focusing on whole, unprocessed foods, lean proteins, abundant vegetables, fruits, and healthy fats provides your body with the fuel it needs while promoting satiety.
• Regular Physical Activity: Incorporating a mix of cardiovascular exercises and strength training not only burns calories but also improves metabolism, boosts mood, and enhances overall health. Even moderate increases in daily activity, like regular walks, can make a significant difference.
• Mindful Eating Practices: Paying attention to hunger and fullness cues, eating slowly, and savoring meals can prevent overeating and foster a healthier relationship with food.

These lifestyle adjustments are not just about “being on a diet”; they are about adopting sustainable habits that will serve you well for a lifetime. At TrimRx, we equip you with resources and unlimited support to navigate these changes, recognizing that a well-rounded approach is key.

TrimRx’s Comprehensive Support System

Our platform is meticulously designed to support you through every aspect of your weight loss journey. We understand that effective weight management extends beyond just prescribing medication. Our comprehensive service includes:

• Expert Medical Consultations: You’ll connect with licensed medical providers who understand the nuances of GLP-1 and dual agonist medications. They conduct thorough evaluations, discuss your health history, and determine the most appropriate treatment plan for you.
• Personalized Treatment Plans: Based on your individual health profile, goals, and eligibility, we offer a range of clinically proven options, from Compounded Semaglutide and Oral Semaglutide to Mounjaro® and Zepbound®. Our commitment to transparent service means our approach remains consistent, regardless of dosage changes or specific medication.
• Necessary Lab Work: To ensure safety and monitor your health, relevant lab tests are included as part of your personalized program.
• Unlimited Support: Your journey is not a solitary one. Our team provides ongoing guidance, answers your questions, and offers motivation, helping you overcome challenges and celebrate successes.
• Convenient Shipping: Medications are shipped directly to your door from our trusted network of FDA-registered and inspected pharmacies, ensuring quality and convenience.

Enhancing Your Journey with Quick-Access Supplements

Beyond prescription medications, we also offer quick-access supplements designed to provide additional support for your overall wellness during the weight loss journey. These supplements do not require a quiz and are available for immediate purchase:

• GLP-1 Daily Support: This supplement is formulated to complement your body’s natural processes, offering daily support for metabolic health.
• Weight Loss Boost: Designed to provide an extra edge, this boost can help optimize your efforts and support your body’s weight management functions.

We believe in empowering you with a full spectrum of tools for success. Whether you are exploring prescription options or seeking complementary support, our resources are designed to help you achieve and maintain a healthier lifestyle.

Your Personalized Path with TrimRx

Embarking on a weight loss journey is a deeply personal experience, and at TrimRx, we are dedicated to honoring that individuality. Our entire approach is built upon the understanding that there is no universal solution; instead, the most effective path is one that is specifically tailored to you.

Our journey began with a shared vision to help individuals embrace healthier lifestyles by merging cutting-edge telehealth innovations with effective weight loss solutions. This vision guides everything we do, from the careful selection of clinically proven medications to the robust support systems we’ve put in place. We believe that sustainable weight loss should be achieved through science, empathy, and a transparent approach.

We offer a diverse range of powerful prescription medications to meet varying needs, including Compounded Semaglutide, Oral Semaglutide, Ozempic®, Wegovy®, Compounded Tirzepatide, Oral Tirzepatide, Mounjaro®, and Zepbound®. For these prescription medications, the first step is always to ensure eligibility and to craft a treatment plan that aligns with your unique health profile and goals. This is where our personalized assessment truly shines.

Our platform is designed to be a user-friendly and supportive space where individuals receive personalized, medically supervised care. We combine advanced medical science with modern technology to deliver compassionate care that respects every individual’s unique journey. Our commitment to transparent service means you can trust that our approach remains consistent, focusing on your safety by working exclusively with FDA-registered and inspected pharmacies for the shipping of your medications.

Are you ready to discover if a personalized, medically supervised weight loss program with TrimRx is the right fit for you? The most effective way to begin understanding your options is by taking the first step.

Take control of your health journey today. We invite you to take our free assessment quiz to see if you qualify for our prescription weight loss medications. This quick, confidential assessment helps us gather the necessary information to connect you with a licensed medical provider who can guide you toward a tailored treatment plan.

In addition to our personalized prescription programs, remember that immediate support is available through our quick-access supplements. Enhance your wellness journey with our GLP-1 Daily Support and Weight Loss Boost, designed to complement your efforts. Together, we can build a foundation for lasting health and well-being.

Conclusion

The journey toward sustainable weight loss is multifaceted, and the emergence of medications like Wegovy (semaglutide) and Mounjaro (tirzepatide) has provided powerful new avenues for individuals seeking effective solutions. We’ve explored the scientific mechanisms behind these medications, highlighting how Wegovy’s GLP-1 agonism and Mounjaro’s dual GIP/GLP-1 agonism both work to regulate appetite and metabolism. While both are clinically proven to induce significant weight loss, recent head-to-head studies suggest that Mounjaro may lead to a greater average percentage of body weight reduction due to its unique dual-action approach.

However, understanding the science is just one piece of the puzzle. We’ve emphasized that the most impactful and enduring weight loss results are achieved when these medications are integrated into a holistic strategy that includes mindful eating, regular physical activity, and robust medical support. Safety remains paramount, and we’ve underscored the importance of medical supervision, dose titration, and adherence to prescribed guidelines to manage potential side effects.

At TrimRx, our commitment is to provide a transparent, empathetic, and results-oriented path to weight loss. We stand by our vision of merging cutting-edge telehealth with effective, personalized care, ensuring that you receive medically supervised treatment through our network of licensed providers and access to medications shipped from FDA-registered and inspected pharmacies. Whether it’s Compounded Semaglutide, Mounjaro®, Zepbound®, or any other advanced option, our focus is on finding the solution that best fits your individual needs.

Your weight loss journey is yours alone, but you don’t have to embark on it by yourself. We offer the tools, the knowledge, and the unwavering support to help you achieve your health goals. Take the first confident step towards a healthier future. Take our free assessment quiz today to explore your personalized treatment options, and remember our GLP-1 Daily Support and Weight Loss Boost are always available to complement your wellness efforts. Together, we can make sustainable weight loss a reality.

FAQ

Q1: What is the primary difference in how Wegovy and Mounjaro work for weight loss?

A1: Wegovy (semaglutide) is a GLP-1 receptor agonist, meaning it mimics the GLP-1 hormone to reduce appetite, slow stomach emptying, and help regulate blood sugar. Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist, mimicking both GLP-1 and GIP hormones. This dual action is believed to provide a more comprehensive approach to appetite regulation and fat metabolism, which may contribute to greater weight loss for some individuals.

Q2: Is one medication more effective than the other for weight loss?

A2: Based on head-to-head clinical trials, tirzepatide (Mounjaro’s active ingredient) has generally shown greater average weight loss compared to semaglutide (Wegovy’s active ingredient). Studies indicate that individuals on tirzepatide may lose a higher percentage of their starting body weight. However, individual results can vary, and a personalized assessment is essential to determine the best treatment for your specific needs. You can begin this process by taking our free assessment quiz.

Q3: What are the common side effects of Wegovy and Mounjaro?

A3: Both medications share similar common side effects, predominantly gastrointestinal issues such as nausea, diarrhea, constipation, vomiting, and abdominal pain. These side effects are typically mild to moderate and often improve as your body adjusts to the medication, especially during the gradual dose titration. Less common side effects can include fatigue, dizziness, and headaches. Our comprehensive service includes doctor consultations to help you manage and understand these potential effects.

Q4: Do I still need to diet and exercise while taking Wegovy or Mounjaro?

A4: Yes, absolutely. Both Wegovy and Mounjaro are most effective when used as part of a holistic weight loss program that includes a calorie-reduced diet and increased physical activity. The medications work by making it easier to adhere to these lifestyle changes by reducing appetite and increasing feelings of fullness. At TrimRx, we emphasize that sustainable weight loss is achieved through a combination of advanced medical science and dedicated lifestyle adjustments, supported by unlimited support and resources, including our GLP-1 Daily Support and Weight Loss Boost supplements.